Amyloidosis: another cause of persistent inflammation in patients treated with anti-tnf alpha treatment

被引：0
|
作者：
Filipescu, I. C. [1 ]
Opris, A. C. [1 ]
Doroltan, P. [1 ]
Andrei, M. [1 ]
Felea, I. [1 ]
Stancu, B. [2 ]
Georgiu, C. [3 ]
Rednic, S. [1 ]
机构：
[1] Univ Med & Pharm Iuliu Hatieganu, Rheumatol Clin Cluj Napoca, Cluj Napoca, Romania
[2] Univ Med & Pharm Iuliu Hatieganu, Surg Clin 2, Cluj Napoca, Romania
[3] Univ Med & Pharm Iuliu Hatieganu, Morphopathol Dept, Cluj Napoca, Romania
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2015年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6.11
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [1] Amyloidosis: Another Cause of Persistent Inflammation in Patients Treated With Anti-TNF Alpha Treatment
    Filipescu, I
    Doroltan, P.
    Andrei, M.
    Damian, L.
    Felea, I
    Stancu, B.
    Georgiu, C.
    Rednic, S.
    PROCEEDINGS OF THE 49TH ANNUAL SCIENTIFIC MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION, 2015, : 179 - 184
  • [2] Anti-TNF treatment in secondary amyloidosis
    Ortiz-Santamaria, V
    Valls-Roc, M
    Sanmartí, M
    Olivé, A
    RHEUMATOLOGY, 2003, 42 (11) : 1425 - 1426
  • [3] Anti-TNF alpha in the treatment of psoriatic arthritis
    Claudepierre, P
    Wendling, D
    Cohen, JD
    PRESSE MEDICALE, 2006, 35 (04): : 647 - 655
  • [4] Anti-TNF alpha
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2010, 49 (500): : 51 - 54
  • [5] AA AMYLOIDOSIS TREATED BY TOCILIZUMAB: EFFICACY IN INFLAMMATORY AND/OR ANTI-TNF ALPHA REFRACTORY FORMS - AN INTERNATIONAL STUDY
    Courties, A.
    Grateau, G.
    Philippe, P.
    Flipo, R. -M.
    Astudillo, L.
    Aubry-Rozier, B.
    Fabreguet, I.
    Fahd, W.
    Fain, O.
    Guggenbuhl, P.
    Hachulla, E.
    Papo, T.
    Richez, C.
    Sibilia, J.
    Morel, J.
    Berenbaum, F.
    Sellam, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 307 - 308
  • [6] Tuberculosis prophylaxis protocol used in patients with anti-TNF alpha treatment
    Guahnon, L
    Erra, A
    Moreno, E
    Tomas, C
    Pigrau, C
    Casellas, F
    Vidal, R
    Barcelo, P
    Marsal, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 405 - 405
  • [7] Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept)
    Pastor, N
    Betlloch, I
    Pascual, JC
    Blanes, M
    Bañuls, J
    Silvestre, JF
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (01) : 152 - 153
  • [8] Tuberculosis Infection Under Anti-TNF Alpha Treatment
    Athimni, Salma
    Slouma, Maroua
    Dhahri, Rim
    Gharsallah, Imen
    Metoui, Leila
    Louzir, Bassem
    CURRENT DRUG SAFETY, 2022, 17 (03) : 235 - 240
  • [9] Another anti-TNF therapy for patients with Crohn's disease
    Cross, Raymond
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 425 - 427
  • [10] OUTCOMES OF THE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ANTI-TNF ALPHA DRUGS IN CLINICAL PRACTICE
    Vallano, A.
    Marsal, S.
    Avila, G.
    Vidal, X.
    Alegre, C.
    Petru-Simon, C.
    Pedros, C.
    Arnau, J. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 38 - 38
12345